GENE ONLINE|News &
Opinion
Blog

mRNA Vaccine
COVID-19 Vaccine
Final Analysis Suggests Pfizer, BioNTech’s COVID-19 Vaccine is Safe with 95% Efficacy
2020-11-18
COVID-19 Vaccine
How Does Moderna’s mRNA Vaccine Measure Up to Pfizer’s?
2020-11-16
COVID-19 Vaccine
Moderna’s Shares Surge Following Claims of 94.5% Efficacy for its COVID-19 Vaccine
2020-11-16
COVID-19 Vaccine
COVID-19: CureVac Announces Promising Phase 1 Results with Lower Vaccine Dosage Than Competitors
2020-11-03
COVID-19 Vaccine
Moderna Gives Updates on Its Diversified Pipeline at R&D Day
2020-09-19
COVID-19
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
COVID-19
Hunt for mRNA-based Coronavirus Vaccine Intensifies after BioNTech’s Alliance with Fosun Pharma, Pfizer
2020-03-17
In-Depth RNA Therapeutics
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
1 2 3 4
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top